Thomas Jonassen Management

Roles

SynAct Pharma AB Stockholm
Management
19.12.202519.12.2025

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
19.12.2025SynAct Pharma AB Stockholm
Bought — open marketAcquisition
via TJ Biotech Holding Aps
3,529SEK 20.45
SEK 72,168.05